Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cell ImpactOSTO:CI -4.55% Receivables Turnover is 1.57 as of Mar. 2026. The stock has 7 warning signs investors should review. Among 3,028 Industrial Products companies, Cell Impact ranks worse than 68.73% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Cell Impact's Revenue for the
three
months ended in Mar. 2026 was kr2.18 Mil. Cell Impact's average Accounts Receivable for the
three
months ended in Mar. 2026 was kr1.38 Mil.
Hence, Cell Impact's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.57.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Cell Impact Receivables Turnover Related Terms
Cell Impact Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Cell Impact's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:CI vs CRS, ATI, MLI: Receivables Turnover Comparison
For the Metal Fabrication subindustry, Cell Impact's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cell Impact Receivables Turnover vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Cell Impact's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Cell Impact's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Impact (OSTO:CI) has a Receivables Turnover of 1.57 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Cell Impact and its competitors. According to the industry distribution chart, Cell Impact ranks #2081 out of 3028 companies in the Industrial Products industry, placing it in the top 68.7%.
Is Cell Impact's Receivables Turnover too high?
Cell Impact's current Receivables Turnover is 1.57. The Industrial Products industry median Receivables Turnover is 4.45. Cell Impact's value of 1.57 is 64.7% below this industry median. Based on the distribution chart, Cell Impact ranks #2081 out of 3028 companies in the Industrial Products industry, which is below the industry midpoint.
How does Cell Impact's Receivables Turnover compare to CRS and ATI?
According to the Industrial Products industry distribution chart, Cell Impact ranks #2081 out of 3028 companies for Receivables Turnover. This places Cell Impact in the lower half of its industry. The industry median Receivables Turnover is 4.45. Cell Impact's value of 1.57 is 64.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for an Industrial Products company?
The median Receivables Turnover among Industrial Products companies is 4.45, based on 3,028 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cell Impact's current Receivables Turnover of 1.57 is 64.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Cell Impact and its competitors. For the Industrial Products industry, the median Receivables Turnover is 4.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Impact's current Receivables Turnover is 1.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Impact stock overvalued right now?
Based on GuruFocus' analysis, Cell Impact (OSTO:CI) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.07 — trading 34.4% above its estimated fair value. The current Receivables Turnover is 1.57 and 64.7% below the Industrial Products industry median of 4.45. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Cell Impact (OSTO:CI), the current Receivables Turnover is 1.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:CI has been successfully added to your 
